Don Mills
Anesthesiology · Newport Beach, CANPI 1700809431
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Abbott at 28.5% of the total. Reporting peaked in 2019 at $2,470 and has fallen 97.5% since, to $61 in 2023. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $25.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$814
- Nevro Corp.$644
- Daiichi Sankyo Inc.$250
- Collegium Pharmaceutical, Inc.$198
- Bioventus LLC$186
- Amgen$141
- plus $624 from 11 others
What the payments were for
- Food & beverage$2,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 7 | $814 |
| Nevro Corp. | 20 | $644 |
| Daiichi Sankyo Inc. | 26 | $250 |
| Collegium Pharmaceutical, Inc. | 15 | $198 |
| Bioventus LLC | 4 | $186 |
| Amgen | 11 | $141 |
| Stimwave Technologies Incorporated | 1 | $120 |
| Boston Scientific | 7 | $120 |
| Nalu Medical, Inc. | 5 | $80 |
| Sentynl Therapeutics, Inc. | 4 | $65 |
| Kaleo, Inc. | 3 | $61 |
| Scilex Pharmaceuticals Inc. | 3 | $58 |
| Pacira Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $23 |
| Forte Bio-pharma LLC | 1 | $23 |
| Pfizer | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$765
- Senza Spinal Cord Stimulation System$458
- Supartz$127
- Morphabond ER$125
How this compares
$2,858 in reported general payments places this provider in the 90th percentile of 5,717 anesthesiology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $1,904 |
| Oxycodone Hcl | 37 | $843 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $729 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $601 |
| Carisoprodol | 26 | $314 |
| Gabapentin | 18 | $207 |
| Alprazolam | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Newport Beach
- Joseph RinehartNewport Beach$190K
- Douglas MestNewport Beach$119K
- Rodd RezvaniNewport Beach$58K
- Timothy CarpenterNewport Beach$45K
- Jack JengSouth San Francisco$1.3M
- Roger PhillipsChico$434K
- David DeyhimyLaguna Hills$344K
- Maxime CannessonLos Angeles$336K
- Alexander RoherSan Diego$282K
- Moody MakarLos Angeles$252K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.